WO2002062983A1 - Levure faisant preuve d'une activite immunoregulatrice des lymphocytes t, son procede de preparation et ses applications - Google Patents

Levure faisant preuve d'une activite immunoregulatrice des lymphocytes t, son procede de preparation et ses applications Download PDF

Info

Publication number
WO2002062983A1
WO2002062983A1 PCT/CN2001/000116 CN0100116W WO02062983A1 WO 2002062983 A1 WO2002062983 A1 WO 2002062983A1 CN 0100116 W CN0100116 W CN 0100116W WO 02062983 A1 WO02062983 A1 WO 02062983A1
Authority
WO
WIPO (PCT)
Prior art keywords
yeast
genes
cell
specific
regulate
Prior art date
Application number
PCT/CN2001/000116
Other languages
English (en)
French (fr)
Inventor
Kamfu Wong
Original Assignee
Six Forest Bio-Science Institute Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Six Forest Bio-Science Institute Limited filed Critical Six Forest Bio-Science Institute Limited
Priority to PCT/CN2001/000116 priority Critical patent/WO2002062983A1/zh
Publication of WO2002062983A1 publication Critical patent/WO2002062983A1/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N13/00—Treatment of microorganisms or enzymes with electrical or wave energy, e.g. magnetism, sonic waves
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0004—Homeopathy; Vitalisation; Resonance; Dynamisation, e.g. esoteric applications; Oxygenation of blood
PCT/CN2001/000116 2001-02-08 2001-02-08 Levure faisant preuve d'une activite immunoregulatrice des lymphocytes t, son procede de preparation et ses applications WO2002062983A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000116 WO2002062983A1 (fr) 2001-02-08 2001-02-08 Levure faisant preuve d'une activite immunoregulatrice des lymphocytes t, son procede de preparation et ses applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2001/000116 WO2002062983A1 (fr) 2001-02-08 2001-02-08 Levure faisant preuve d'une activite immunoregulatrice des lymphocytes t, son procede de preparation et ses applications

Publications (1)

Publication Number Publication Date
WO2002062983A1 true WO2002062983A1 (fr) 2002-08-15

Family

ID=4574770

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000116 WO2002062983A1 (fr) 2001-02-08 2001-02-08 Levure faisant preuve d'une activite immunoregulatrice des lymphocytes t, son procede de preparation et ses applications

Country Status (1)

Country Link
WO (1) WO2002062983A1 (zh)

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375651A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for white blood cell activation and proliferation
EP1375652A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for HIV-Infected Subjects
WO2004108919A1 (en) * 2003-06-11 2004-12-16 Ultra Biotech Limited Biological compositions comprising yeast cells and methods for treatment of cancer
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US9320768B2 (en) 2009-08-26 2016-04-26 Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8402388A (nl) * 1983-08-01 1985-03-01 Shigezo Udaka Geneesmiddel spf-100 en werkwijze voor de bereiding hiervan.
SU1174475A1 (ru) * 1984-02-10 1985-08-23 Предприятие П/Я А-1067 Способ обработки пивных дрожжей
SU1592328A1 (ru) * 1988-05-16 1990-09-15 Ki T I Pishchevoj Promy Cпocoб aktиbaции xлeбoпekaphыx дpoжжeй
EP0615757A1 (fr) * 1993-03-18 1994-09-21 Georges Serge Grimberg Composition thérapeutique nouvelle ayant un effet immunostimulant

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8402388A (nl) * 1983-08-01 1985-03-01 Shigezo Udaka Geneesmiddel spf-100 en werkwijze voor de bereiding hiervan.
SU1174475A1 (ru) * 1984-02-10 1985-08-23 Предприятие П/Я А-1067 Способ обработки пивных дрожжей
SU1592328A1 (ru) * 1988-05-16 1990-09-15 Ki T I Pishchevoj Promy Cпocoб aktиbaции xлeбoпekaphыx дpoжжeй
EP0615757A1 (fr) * 1993-03-18 1994-09-21 Georges Serge Grimberg Composition thérapeutique nouvelle ayant un effet immunostimulant

Cited By (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1375651A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for white blood cell activation and proliferation
EP1375652A3 (en) * 2002-06-28 2004-01-07 Ultra Biotech Limited Oral compositions for HIV-Infected Subjects
WO2004108919A1 (en) * 2003-06-11 2004-12-16 Ultra Biotech Limited Biological compositions comprising yeast cells and methods for treatment of cancer
US6984507B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of lung cancer
US6984508B2 (en) 2003-06-11 2006-01-10 Ultra Biotech Limited Biological compositions and methods for treatment of cervical cancer
US6987012B2 (en) 2003-06-11 2006-01-17 Ultra Biotech Limited Biological compositions and methods for treatment of colorectal cancer
US6989253B2 (en) 2003-06-11 2006-01-24 Ultra Biotech Limited Biological compositions and methods for treatment of testicular cancer
US7201906B2 (en) 2003-06-11 2007-04-10 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204988B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7204987B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Biological compositions and methods for treatment of prostate cancer
US7204986B2 (en) 2003-06-11 2007-04-17 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7208158B2 (en) 2003-06-11 2007-04-24 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7214377B2 (en) 2003-06-11 2007-05-08 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7220416B2 (en) 2003-06-11 2007-05-22 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223404B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223405B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepareompositions comprising yeast treated with electromagnetic energy
US7223402B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223401B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223403B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7223400B2 (en) 2003-06-11 2007-05-29 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US7226600B2 (en) 2003-06-11 2007-06-05 Ultra Biotech Limited Method to prepare compositions comprising yeast treated with electromagnetic energy
US9320768B2 (en) 2009-08-26 2016-04-26 Milmed Ab Composition for treatment of neurodegenerative diseases or disorders, method and use comprising electromagnetically irradiated yeast

Similar Documents

Publication Publication Date Title
WO2002062983A1 (fr) Levure faisant preuve d'une activite immunoregulatrice des lymphocytes t, son procede de preparation et ses applications
WO2002062985A1 (fr) Levure faisant preuve d'un activite immunoregulatrice cellulaire nk, son procede de preparation et ses applications
WO2002062981A1 (fr) Immunoregulateur humain de levure et son procede de preparation
Chen et al. Arsenic: a global environmental challenge
WO2002062984A1 (fr) Levure faisant preuve d'une activite immunoregulatrice du lymphocyte k, son procede de production et ses applications
Li et al. A novel lectin with potent antitumor, mitogenic and HIV-1 reverse transcriptase inhibitory activities from the edible mushroom Pleurotus citrinopileatus
WO2003078431A8 (de) Aza- bicyclische n-biarylamide mit affinität zum alpha7 nikotinischen acetylcholin-rezeptor
WO2002062982A1 (fr) Levure faisant preuve d'une activite immunoregulatrice des lymphocytes b, son procede de preparation et ses applications
WO2001092308A3 (en) Cystine-knot polypeptides: cloaked-2 molecules and uses thereof
WO2004016733A3 (en) Nucleic acid and corresponding protein entitled 251p5g2 useful in treatment and detection of cancer
EP1375651A3 (en) Oral compositions for white blood cell activation and proliferation
WO2006018632A3 (en) Cell therapy with exo 1
Lai et al. The marine Catenovulum agarivorans MNH15 and dextranase: removing dental plaque
Kanpiengjai et al. Characterization of Sporidiobolus ruineniae A45. 2 cultivated in tannin substrate for use as a potential multifunctional probiotic yeast in aquaculture
TW200734638A (en) Method for the diagnosis of thromboembolic and coronary heart diseases
WO2007099348A3 (en) Cathepsin propeptide and uses thereof
Jang et al. Antidiabetic, anticholesterol, and antioxidant activity of Gryllus bimaculatus fermented by Bacillus and Lactobacillus strains
WO2005042699A3 (en) Modified polypeptides with therapeutic activity and methods of use
WO1997015668A3 (en) Methods and compositions comprising glut-2 and glut-2 chimeras
WO2004009781A3 (en) Process for regulating gene expression
WO2003006630A3 (en) Nucleic acid free ghost preparations
CN101701191B (zh) 好食脉孢霉及由该好食脉孢霉培制纤溶酶的方法
WO2002074921A3 (en) Methods for isolating proteins expressed by dendritic cells
WO1995034649A3 (en) Polycystic kidney disease 1 gene and uses thereof
WO2001085785A3 (en) Ph domain-interacting protein

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGHTS PURSUANT TO RULE 69(1) EOC

122 Ep: pct application non-entry in european phase
NENP Non-entry into the national phase

Ref country code: JP